Free from Publisher

Blocking of type 1 angiotensin II receptor inhibits T-lymphocyte activation and IL-2 production

S Tawinwung, N Petpiroon, P Chanvorachote - in vivo, 2018 - iv.iiarjournals.org
Background/Aim: Novel information on the role of endogenous compounds in regulating
physiological and pathological process are of interest, as it may lead to the development of …
被引用次数：13 相关文章
[PDF] iiarjournals.org

[PDF][PDF] Blocking of Type 1 Angiotensin II Receptor Inhibits T-lymphocyte Activation and IL-2 Production

S TAWINWUNG, N PETPIROON… - in vivo, 2018 - iv.iiarjournals.org
Background/Aim: Novel information on the role of endogenous compounds in regulating
physiological and pathological process are of interest, as it may lead to the development of …
[HTML] nih.gov

[HTML][HTML] Blocking of Type 1 Angiotensin II Receptor Inhibits T-lymphocyte Activation and IL-2 Production

S TAWINWUNG, N PETPIROON… - In Vivo, 2018 - ncbi.nlm.nih.gov
Background/Aim: Novel information on the role of endogenous compounds in regulating
physiological and pathological process are of interest, as it may lead to the development of …

Blocking of Type 1 Angiotensin II Receptor Inhibits T-lymphocyte Activation and IL-2 Production

S Tawinwung, N Petpiroon… - In vivo (Athens …, 2018 - pubmed.ncbi.nlm.nih.gov
Background/aim Novel information on the role of endogenous compounds in regulating
physiological and pathological process are of interest, as it may lead to the development of …

Blocking of Type 1 Angiotensin II Receptor Inhibits T-lymphocyte Activation and IL-2 Production.

S Tawinwung, N Petpiroon… - In Vivo (Athens …, 2018 - europepmc.org
Materials and methods Jurkat T-cells were treated with AGT1R inhibitor candesartan and
stimulated with phorbol myristate acetate (PMA) and ionomycin. T-Cell activation, associated …